-
2022-500305-40-00
9
2024-04-10
Small Lymphocytic Lymphoma
-
2023-504899-25-00
5
2024-04-04
Metastatic castration resistant prostate cancer
-
2023-503412-33-00
5
2024-03-29
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cance
-
2023-506792-94-00
11
2024-03-04
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
-
2024-510892-40-00
6
2024-02-29
Acute myocardial infarction complicated by cardiogenic shock
-
2023-506698-36-00
5
2024-02-02
low-volume metastatic castration-sensitive prostate cancer
-
2023-505379-61-00
4
2024-01-17
Acute Myeloid Leukaemia
-
2023-504637-42-01
6
2023-12-21
aortic valve stenosis
-
2024-518844-20-00
10
2023-10-03
Treatment of Acute Gout Flare
-
2022-501620-26-00
6
2023-05-15
prosthetic joint infection
-
2023-508389-13-00
5
2022-11-08
Combined endpoint of all-cause mortality, kidney failure, and hospital
-
2023-503267-42-00
5
2022-06-10
Patients with a histological diagnosis of mismatch- repair deficient h
-
2024-513797-22-00
5
2022-03-09
HER2 positive esophageal adenocarcinoma
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-512526-28-00
5
2020-10-28
Locally recurrent rectal cancer
-
2023-505449-18-00
4
2020-07-23
Patients with relapsed CLL
-
2023-509152-33-00
4
2016-07-25
Advanced solid tumor
-
2024-520155-24-00
4
2025-10-16
Metastatic castration resistant prostate cancer (mCRPC)
-
2024-519773-19-00
5
2025-07-31
Gastroesophageal Junction Adenocarcinoma
-
2024-517356-35-00
4
2025-07-29
Moderately Active Rheumatoid Arthritis
-
2024-519386-21-01
5
2025-01-29
Gestational diabetes mellitus
-
2024-518171-59-00
11
2025-01-23
Prostate Cancer
-
2024-511650-50-00
5
2025-01-17
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
-
2024-517467-23-00
5
2024-11-29
steroid sensitive idiopathic nephrotic syndrome